Ascension Health will form a joint venture with a division of Envision Healthcare to provide an array of post-acute services, including home care, hospice care, and infusion therapy.
Ascension Health will form a joint venture with a division of Envision Healthcare to provide an array of post-acute services. The arrangement will include home care, hospice care, and infusion therapy, and under the agreement Envision’s subsidiary, Evolution Health, will be an exclusive partner to provide these services.
The new joint venture will include 5 of Ascension Health’s 23 communities and will begin at the end of this year. According to estimates, revenues should be $75-$100 million, and Ascension expects to expand into additional communities over the next 3 years.
“This agreement furthers Ascension’s focus on delivering person-centered care to individuals in a variety of settings, which is key to our efforts to manage the health of patient populations,” Anthony R. Tersigni, EdD, FACHE, president and chief executive officer (CEO) of Ascension, said in a statement. “Providing service in the home and through alternative facilities to people in need of care, including those who are poor and vulnerable, is one way we extend our ministry beyond hospital walls and reach individuals and families where and when they need us.”
The partnership will expand the footprint of Evolution Health by providing services in new markets. President and CEO William A. Sanger expects that working together with Ascension to deliver post-acute and home care services will improve both patient outcomes and satisfaction.
The Ascension Health Senior Care unit was only formed on July 30 and ranks as the second-largest not-for-profit long-term care provider in the United States. The organization oversees 5,568 senior care/senior living beds and 3 Program of All-inclusive Care for the Elderly.
“We believe there is much to be learned by working with Evolution Health in a way that ensures the most effective and efficient care across our national health ministry in support of our Mission of serving all persons,” added Robert J. Henkel, FACHE, president and CEO of Ascension Health, a direct subsidiary of Ascension.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
What We’re Reading: FDA Approves UTI Antibiotic; Ozempic, Wegovy Price Investigation; US Births Fall
April 25th 2024The FDA recently approved an antibiotic for the treatment of urinary tract infections (UTIs) in women; a Senate committee recently launched an investigation into the prices of Novo Nordisk’s diabetes and weight loss drugs; US births fell last year, resuming a national slide after a previous increase during the pandemic.
Read More
HOPE-CAT Can Identify Maternal Cardiovascular Risk 2 Months Earlier Than Doctors, Study Says
April 25th 2024In a retrospective study, the machine learning tool was able to screen for potential risks of cardiovascular disease nearly 60 days before the patient's medical record showed any signs of a related condition or before they were officially diagnosed or treated for it.
Read More